IL6R and viral infectious disease: In conclusion, our results show that blockade of IL-6R in hospitalized patients with COVID-19 pneumonia produces only minimal changes in HDL-C levels, suggesting that the viral infection, and not IL-6–mediated inflammation, is the main driver of HDL-C depression.